Also known as: Refractory, metastatic squamous cell Non-small cell lung cancer
DrugDrug NameDrug Description
DB08916AfatinibAfatinib is a tyrosine kinase inhibitor which is a 4-anilinoquinazoline. It is prepared has the dimaleate salt. FDA approved on July 12, 2013.
DrugDrug NamePhaseStatusCount